Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR7.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR9.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR4.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR3.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR1.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR6.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR2.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR5.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR8.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR27.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR28.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR32.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR25.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR34.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR14.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR35.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR22.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR20.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR15.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR30.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR12.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR11.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR44.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR43.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR33.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR24.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR10.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR19.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR16.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR26.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR21.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR17.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR36.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR40.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR37.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR13.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR41.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR29.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR23.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR38.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR31.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR39.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR42.htm
EX-31.2 - EX-31.2 - IMPLANT SCIENCES CORPimsc12033110qa1_ex31z2.htm
EX-31.1 - EX-31.1 - IMPLANT SCIENCES CORPimsc12033110qa1_ex31z1.htm
EX-32.2 - EX-32.2 - IMPLANT SCIENCES CORPimsc12033110qa1_ex32z2.htm
EX-32.1 - EX-32.1 - IMPLANT SCIENCES CORPimsc12033110qa1_ex32z1.htm
XML - IDEA: XBRL DOCUMENT - IMPLANT SCIENCES CORPR18.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q/A

(Amendment No. 1)

(Mark One)

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:

March 31, 2012

or

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from:

 

to

 


Commission File Number:

001-14949


Implant Sciences Corporation

(Exact name of registrant as specified in its charter)


Massachusetts

(State or other jurisdiction of

incorporation or organization)

 

04-2837126

(I.R.S. Employer Identification No.)

600 Research Drive, Wilmington, Massachusetts

(Address of principal executive offices)

 

01887

(Zip Code)


(978) 752-1700

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x  No q

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes x  No q

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

q  Large Accelerated Filer

q  Accelerated Filer

q  Non-accelerated Filer

x  Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes q  No x

As of April 30, 2012, there were 35,847,996 shares of the registrant’s Common Stock outstanding.




EXPLANATORY PARAGRAPH

Implant Sciences Corporation is filing this Amendment No. 1 (“Amendment No. 1”) to its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2012, originally filed with the Securities and Exchange Commission on May 15, 2012 (the “Original Filing”), for the sole purpose of including Interactive Data Files (Exhibit 101) formatted in XBRL (“Extensible Business Reporting Language”) with block tagging of the notes to the condensed consolidated financial statements as required by Rule 405 of Regulation S-T. We are also filing currently dated certifications of our Chief Executive Officer and Chief Financial Officer (Exhibits 31.1, 31.2, 32.1 and 32.2, respectively), as required under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.

No changes have been made to the Original Filing other than the furnishing of the exhibits as set forth in Item 6 herein. This Amendment No. 1 continues to speak as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the Form 10-Q.





- 2 -






PART II.

OTHER INFORMATION


Item 6.

Exhibits

Exhibit No.

Description

31.1*

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*

Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**

XBRL Instance Document.

101.SCH**

XBRL Taxonomy Extension Schema Document.

101.CAL**

XBRL Taxonomy Extension Calculation Linkbase Document.

101.LAB**

XBRL Taxonomy Extension Label Linkbase Document.

101.PRE**

XBRL Taxonomy Extension Presentation Linkbase Document.

101.DEF**

XBRL Taxonomy Extension Definition Linkbase Document.

 

 


*

Included herewith.

**

Filed with this report in accordance with Rule 406T of Regulation S-T, the information in these exhibits shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subjected to liability under that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.










SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Implant Sciences Corporation

 

By:

/s/ Glenn D. Bolduc

 

 

Glenn D. Bolduc

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

 

 

By:

/s/ Roger P. Deschenes

 

 

Roger P. Deschenes

Chief Financial Officer

(Principal Financial Officer and Chief Accounting Officer)

 

 

Dated:  November 20, 2012